Search results for "HIV"

showing 10 items of 1527 documents

Let's End HepC: modelling public health epidemiological policies applied to Hepatitis C in Spain

2022

Background: The WHO has defined international targets toward the elimination of hepatitis C by 2030. Most countries cannot be on track to achieve this goal unless many challenges are surpassed. The Let's End HepC (LEHC) tool aims to contribute to the control of hepatitis C. The innovation of this tool combines the modelling of public health policies (PHP) focused on hepatitis C with epidemiological modelling of the disease, obtaining a unique result that allows to forecast the impact of policy outcomes. The model was applied to several countries, including Spain.Methods: To address the stated objective, we applied the “Adaptive Conjoint Analysis” for PHP decision-making and Markov Chains in…

Public healthCONJOINT-ANALYSISPublic Health Environmental and Occupational HealthHCV INFECTIONHIVHealth literacyPublic PolicyHepacivirusVIRUS-INFECTIONAntiviral AgentsHepatitis CDISEASEModellingPREVALENCESpainPEOPLEHumansPublic aspects of medicineRA1-1270BURDENPublic health policiesOriginal Research
researchProduct

Evolución de la declaración de la tuberculosis en un área sanitaria de la Comunidad Valenciana desde 1987 hasta 1999

2001

Objetivos La infradeclaracion de la tuberculosis (TBC) es un hecho frecuente a escala mundial que ha sido escasa-mente estudiado en nuestro pais. El objetivo de nuestro es-tudio fue conocer el estado de la declaracion de los casos de TBC en nuestra area sanitaria Material y metodo Desde 1987 a 1999 se estudio de for-ma directa la incidencia y el estado de declaracion de los casos de TBC en nuestra area (censo: 106.632 habitantes). Los casos se obtuvieron desde el registro de EDO, anatomia patologica y bacteriologia, con posterior revision de la historia clinica Resultados Se diagnosticaron 410 casos de TBC, de los cuales 378 eran recientes del area (incidencia media anual: 27 por 100.000 ha…

Pulmonary and Respiratory Medicinebusiness.industryHuman immunodeficiency virus (HIV)Medicinebusinessmedicine.disease_causeHumanitiesArchivos de Bronconeumología
researchProduct

HIV plays (and wins) a game of T cell Brinkmanship.

2013

HIV, unlike other viruses, may benefit from immune recognition by preserving the sequence of its T cell epitopes, thereby enhancing transmission between cells.

QH301-705.5T cellImmunologyEpitopes T-LymphocyteHIV InfectionsMicrobiologyGeneral Biochemistry Genetics and Molecular BiologyEpitopeVirusViral EvolutionImmune systemAntigenImmunodeficiency VirusesVirologymedicineCytotoxic T cellHumansComputer SimulationBiology (General)BiologyImmune EvasionEvolutionary BiologyGeneral Immunology and MicrobiologybiologyGeneral NeuroscienceViral Immune Evasionbiochemical phenomena metabolism and nutritionAcquired immune systemVirologymedicine.anatomical_structureImmunologybiology.proteinHIV-1AntibodyGeneral Agricultural and Biological SciencesResearch ArticlePLoS biology
researchProduct

HIGHLY EXCITED VIBRATIONAL STATES OF CYCLIC MOLECULES INVESTIGATED BY I.C.L.A SPECTROSCOPY WITH PHOTOACOUSTIC DETECTION

1991

The spectra of the fourth and fifth CH stretching overtones of cyclohexene and cyclopentene molecules and of some of their selectively deuterated derivatives have been measured by dye laser intracavity spectroscopy with photoacoustic detection. The intramolecular relaxation of the vibrational energy occurs principally through Fermi resonances with CH2 bending combinations in cyclohexene and through a coupling between the stretching and the ring puckering motions in cyclopentene.

Quantitative Biology::BiomoleculesChemistryExcited state[PHYS.HIST]Physics [physics]/Physics archivesAnalytical chemistryGeneral Physics and AstronomyMoleculePhysical chemistryPhotoacoustic imaging in biomedicinePhysics::OpticsPhysics::Chemical PhysicsSpectroscopy3. Good health
researchProduct

Molecular modelling and QSAR in the discovery of HIV-1 integrase inhibitors

2007

The treatment regimens for the HIV-1 have mainly included reverse transcriptase or protease inhibitors but their long-term clinical utility is limited by severe side effects and viral drug resistance. A new attractive target for chemotherapeutic intervention can be the Integrase enzyme, that mediates the integration of HIV-1 DNA into a host chromosome, for which there is no known counterparts in the host cell. A number of derivatives have been found to inhibit IN in in vitro assays, but no successful drug based on them has emerged so far, although many compounds have been proposed. Moreover most of the inhibitors do not belong to a very precise structural class: this fact makes these compou…

Quantitative structure–activity relationshipProteasebiologymedicine.medical_treatmentIntegrase inhibitorDrug designGeneral MedicineComputational biologyDe novo design Docking HIV-1 integrase inhibitors Molecular dynamics Molecular modelling Pharmacophore QSARBioinformaticsIntegraseDocking (molecular)Host chromosomeDrug Discoverybiology.proteinmedicineMolecular MedicinePharmacophore
researchProduct

Search for scalar leptoquarks from Z$^0$ decays

1992

We have searched for pair produced scalar leptoquarks each decaying to a quark and a charged lepton in a sample of 116 000 hadronic Z0 events produced at LEP. No candidate was detected and cross section and branching ratio limits are set for the above process at 95% CL. Mass limits are found to be about 42 GeV/c2 depending only slightly on the models used and a coupling times branching ratio exclusion line is drawn for a scalar leptoquark with a free coupling. We have also probed the mass region above 45 GeV/c2 for a singly produced scalar leptoquark and set limits on the cross section and the coupling lambda(2)/4-pi up to 60 GeV.

QuarkLibraryNuclear and High Energy PhysicsParticle physicsLUND MONTE-CARLOElectron–positron annihilationHadronDigitisationArchive01 natural sciencesJET FRAGMENTATIONPHYSICSNuclear physicsLUND MONTE-CARLO; JET FRAGMENTATION; HADRONIC DECAYS; E+E; PHYSICS; BOSON0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Leptoquark010306 general physicsPhysicsFoucault010308 nuclear & particles physicsBranching fractionHigh Energy Physics::PhenomenologyScalar (physics)BOSONE+EFísica nuclearHigh Energy Physics::ExperimentHADRONIC DECAYSParticle Physics - ExperimentLepton
researchProduct

Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection.

2016

The treatment of HCV infection has seen significant progress, particularly since the approval of new direct-acting antiviral drugs. However these clinical achievements have been made despite an incomplete understanding of HCV replication and within-host evolution, especially compared with HIV-1. Here, we undertake a comprehensive analysis of HCV within-host evolution during chronic infection by investigating over 4000 viral sequences sampled longitudinally from 15 HCV-infected patients. We compare our HCV results to those from a well-studied HIV-1 cohort, revealing key differences in the evolutionary behaviour of these two chronic-infecting pathogens. Notably, we find an exceptional level o…

RNA viruses0301 basic medicineMaleHepacivirusHIV InfectionsHepacivirusPathology and Laboratory Medicinemedicine.disease_causeVirus ReplicationHepatitis0302 clinical medicineImmunodeficiency VirusesMedicine and Health Sciences2.2 Factors relating to the physical environmentChronicAetiologylcsh:QH301-705.5Data Managementeducation.field_of_studybiologyHepatitis C virusLiver Diseasevirus diseasesHepatitis C3. Good healthPhylogeneticsInfectious DiseasesMedical MicrobiologyViral PathogensViral evolutionVirusesEvolutionary RateHIV/AIDS030211 gastroenterology & hepatologyFemalePathogensInfectionResearch Articlelcsh:Immunologic diseases. AllergyComputer and Information SciencesEvolutionary ProcessesEvolutionHepatitis C virusPopulationChronic Liver Disease and CirrhosisImmunologyMicrobiologyViral EvolutionVirusEvolution Molecular03 medical and health sciencesHepatitis - CVirologyRetrovirusesGeneticsmedicineHumansEvolutionary SystematicsEvolutionary dynamicseducationMicrobial PathogensMolecular BiologyTaxonomyEvolutionary BiologyFlavivirusesPopulation BiologyLentivirusOrganismsBiology and Life SciencesHIVMolecularHepatitis C Chronicbiology.organism_classificationVirologyHepatitis virusesOrganismal EvolutionViral ReplicationChronic infection030104 developmental biologyEmerging Infectious Diseaseslcsh:Biology (General)Viral replicationMicrobial EvolutionImmunologyHIV-1Parasitologylcsh:RC581-607Digestive DiseasesPopulation GeneticsFollow-Up Studies
researchProduct

APOBEC4 Enhances the Replication of HIV-1

2016

APOBEC4 (A4) is a member of the AID/APOBEC family of cytidine deaminases. In this study we found a high mRNA expression of A4 in human testis. In contrast, there were only low levels of A4 mRNA detectable in 293T, HeLa, Jurkat or A3.01 cells. Ectopic expression of A4 in HeLa cells resulted in mostly cytoplasmic localization of the protein. To test whether A4 has antiviral activity similar to that of proteins of the APOBEC3 (A3) subfamily, A4 was co-expressed in 293T cells with wild type HIV-1 and HIV-1 luciferase reporter viruses. We found that A4 did not inhibit the replication of HIV-1 but instead enhanced the production of HIV-1 in a dose-dependent manner and seemed to act on the viral L…

RNA virusesMale0301 basic medicineMolecular biologylcsh:MedicineArtificial Gene Amplification and ExtensionCytidinePathology and Laboratory MedicineVirus ReplicationBiochemistryPolymerase Chain ReactionJurkat cellschemistry.chemical_compoundCytidine deaminationImmunodeficiency VirusesTranscription (biology)TestisMedicine and Health Scienceslcsh:SciencePromoter Regions GeneticMultidisciplinaryCytidineTransfectionEnzymesImmunoblot AnalysisMedical MicrobiologyDeaminationViral PathogensViruses293T cellsCell linesPathogensOxidoreductasesBiological culturesLuciferaseResearch ArticleMolecular Probe TechniquesDNA constructionBiologyMicrobiologyCell Line03 medical and health sciencesCytidine DeaminaseRetrovirusesHumansMicrobial PathogensHIV Long Terminal Repeat030102 biochemistry & molecular biologylcsh:RLentivirusHEK 293 cellsOrganismsBiology and Life SciencesHIVProteinsPromoterMolecular biologyResearch and analysis methodsMolecular biology techniques030104 developmental biologychemistryPlasmid ConstructionHIV-1Enzymologylcsh:QEctopic expressionCloningPLOS ONE
researchProduct

Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled…

2017

Dysbalance in gut microbiota has been linked to increased microbial translocation, leading to chronic inflammation in HIV-patients, even under effective HAART. Moreover, microbial translocation is associated with insufficient reconstitution of CD4+T cells, and contributes to the pathogenesis of immunologic non-response. In a double-blind, randomised, placebo-controlled trial, we recently showed that, compared to placebo, 12 weeks treatment with probiotic Saccharomyces boulardii significantly reduced plasma levels of bacterial translocation (Lipopolysaccharide-binding protein or LBP) and systemic inflammation (IL-6) in 44 HIV virologically suppressed patients, half of whom (n = 22) had immun…

RNA virusesMale0301 basic medicinePlacebo-controlled studylcsh:MedicineHIV InfectionsGut floraPathology and Laboratory MedicineSystemic inflammationlaw.inventionPlacebosProbiotic0302 clinical medicineImmunodeficiency ViruseslawMedicine and Health SciencesMedicinelcsh:ScienceImmune ResponseMultidisciplinarybiologyMicrobiotaGenomicsMiddle AgedProbiòticsBacterial PathogensIntestinesSaccharomyces boulardiiMedical MicrobiologyViral PathogensVirusesFemale030211 gastroenterology & hepatologyPathogensmedicine.symptomResearch ArticleSaccharomyces boulardiiAdultImmunologyMicrobial GenomicsMicrobiologySaccharomyces03 medical and health sciencesSigns and SymptomsImmune systemDouble-Blind MethodDiagnostic MedicineRetrovirusesGeneticsVIH (Virus)HumansMicrobiomeMicrobial PathogensInflammationClostridiumBacteriabusiness.industryProbioticsGut BacteriaLentivirusLachnospiraceaelcsh:ROrganismsFungiBiology and Life SciencesHIVbiology.organism_classificationYeast030104 developmental biologyImmunologylcsh:QMicrobiomebusinessPLoS ONE
researchProduct

Sequential Cross-Sectional Surveys in Orange Farm, a Township of South Africa, Revealed a Constant Low Voluntary Medical Male Circumcision Uptake amo…

2016

Background WHO recommends a male circumcision (MC) prevalence rate higher than 80% to have a substantial impact on the HIV-AIDS epidemic in Eastern and Southern Africa. Orange Farm, a township in South Africa, has a free-for-service voluntary medical male circumcision (VMMC) clinic in operation since 2008. Following an intense campaign from 2008 to 2010, MC prevalence rate increased to 55.4% (ANRS-12126). Ongoing and past VMMC campaigns focused on youths, through school talks, and adults at a community level. The main objective of the study was to assess the change in MC prevalence rate among adults aged 18–19 and 18–49 years in the past 5 years. Methods A cross-sectional survey (ANRS-12285…

RNA virusesMaleCross-sectional studyEpidemiologyPrevalenceSocial Scienceslcsh:MedicineHIV InfectionsOrange (colour)Pathology and Laboratory MedicineGeographical locationsCultural AnthropologySouth Africa0302 clinical medicineImmunodeficiency VirusesSociologyEnvironmental protectionCircumcisionMedicine and Health SciencesPrevalenceMedicine030212 general & internal medicineYoung adultReproductive System Procedureslcsh:ScienceMultidisciplinarySchoolsMiddle Aged3. Good healthReligionMale circumcisionMedical MicrobiologyHIV epidemiologyViral PathogensVirusesInfectious diseasesPathogens0305 other medical scienceDemand creationResearch ArticleAdultAdolescentSurgical and Invasive Medical ProceduresViral diseasesMicrobiologyEducation03 medical and health sciencesYoung AdultRetrovirusesAdultsHumansSex organMicrobial Pathogens030505 public healthbusiness.industryLentiviruslcsh:ROrganismsBiology and Life SciencesHIVPatient Acceptance of Health CareCross-Sectional StudiesCircumcision MaleTurnoverAge GroupsAnthropologyPeople and PlacesAfricaPopulation Groupingslcsh:Qbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyDemography
researchProduct